Skip to content
Explore the latest in technology, innovation, and digital t…

Zimbabwe Turns Down ‘One-Sided’ American Healthcare Assistance Package Due to Data Concerns

Health aid image
The offered US financial assistance was aimed at programmes for HIV/Aids treatment and prevention, tuberculosis, and malaria.

The nation of Zimbabwe has rejected a substantial American health deal valued at $367m (272 million pounds) spanning five years because of Washington's request for confidential information.

This move was revealed after a official document dated December was leaked, indicating that President Emmerson Mnangagwa felt the arrangement was "lopsided".

A government spokesperson has since stated that the United States was demanding access to biological samples for scientific study and commercial gain but was not willing to share the benefits from any future medical innovations.

"We will now turn to the challenging and unfortunate process of ending our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.

The US Embassy noted the US had furnished more than $1.9bn for health programmes to Zimbabwe over the last twenty years.

A medical body in Zimbabwe has called for continued talks to find a deal acceptable to both sides so the country's vital HIV treatment initiative can continue.

Broader Background

Zimbabwe's decision comes after a comparable situation in Kenya, where a high court suspended a similar health funding agreement following legal challenges were raised about the safety of Kenyans' health data.

Since returning to the presidency recently, US President Donald Trump has drastically cut foreign aid and closed the US Agency for International Development (USAID).

The agency had overseen assistance for the American government, but Trump claimed its spending was "wasteful" and his administration was seeking government-to-government agreements to boost transparency and accountability.

Based on reports, 16 African countries have to date agreed to these new agreements, representing over $18.3bn in committed funds.

Details of the Declined Deal

The money for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".

"It is our view this cooperation could have provided extraordinary advantages for Zimbabwean communities, especially the 1.2 million currently receiving HIV treatment via American-funded initiatives," the Ambassador said.

However, government spokesperson Nick Mangwana said the arrangement was "unfair".

"The proposal required Zimbabwe to provide its biological resources and data for a long time, without any equivalent assurance of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could result from that provided information," Mangwana explained.

"Put simply, our country would provide the basic resources for medical research without any assurance that the final treatments would be accessible to our citizens should a new health crisis arise."

Sovereignty and International Frameworks

Mangwana further said that the American exit from the World Health Organization (WHO) and its pursuit of bilateral health agreements were disrupting frameworks previously established through the global health agency.

The spokesperson cited its Pandemic Benefit-Sharing scheme created to deal with future pandemics.

"This system is intended to guarantee that when a country contributes its samples, the benefits – including vaccines and treatments – are shared equitably, not commercialised solely by those with the funds to develop them."

The government's concerns regarding the US deal "are not meant as anti-American sentiment," Mangwana stressed.

"We are open to ongoing discussions with our US partners on how subsequent collaboration might be structured in a manner that honours the independence and dignity of each country."

Health Experts Reaction

A leading public health body expressed it recognised the official position, but recommended that talks need to persist considering much of the nation's Aids initiatives depended on foreign aid.

"In cases where technical issues arise, such as those involving information security or agreement terms, these can frequently be addressed through detailed discussion and mutually agreed protections," it commented.

This impasse underscores the continuing tensions between receiving crucial foreign assistance and protecting local interests in an ever more data-driven world.

DC
Written by

David Carlson

A tech journalist with over a decade of experience covering digital transformation and startup ecosystems across Europe.

Krypton House

Type to search articles.